Echo-Xpats: Roche Diagnostics added to Pharmaceutical Clientele

Echo-Xpats today announces a new relocation agreement with Roche Diagnostics, a research-focused healthcare company and one of the world’s leaders in in-vitro diagnostics. The company discovers, develops and provides innovative diagnostic and therapeutic products and services that deliver significant benefits to patients and healthcare professionals. Roche Diagnostics has decided to utilize Echo-Xpats to execute relocation service packages for its new employees moving to the UAE and the Middle East to further support their growth strategy in 2016.

Aaron Mitchell, Echo-Xpats’ Business Development Manager, explains “here at Echo-Xpats we have been working hard to position Echo-Xpats in the leading markets and industries within the region. Having developed the essential foundations of an excellent partnership with Roche Diagnostics, we intend to keep and nurture a long term relationship with them which would not only help them in their growth strategy in the region but also help further cement Echo-Xpats’ reputation in this industry.” 

Adding Roche Diagnostics to Echo-Xpats clientele supports the continued growth of the company. The Echo-Xpats team is currently partnered with several other key players in the pharmaceutical industry and is continuing to look at expanding their service offerings. The company’s dedication to providing a personalized relocation service and its unique approach to relocation is attracting interest from many different companies across several industries.

“Our unique selling points are our people, the quality of service delivery and our innovative technology, by placing these at the core of our marketing and business development strategy we believe that we outperform our competitors and deliver a superior service. Being able to go above and beyond our competitors is essential in convincing potential clients that their relocation requirements are best served by Echo-Xpats” David Donnelly, Managing Partner, added.